{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T14:41:43Z","timestamp":1786545703577,"version":"build-2736575974"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1111\/j.1572-0241.2008.02180.x","type":"journal-article","created":{"date-parts":[[2008,10,3]],"date-time":"2008-10-03T10:43:35Z","timestamp":1223030615000},"page":"3063-3070","source":"Crossref","is-referenced-by-count":158,"title":["Mycophenolate Mofetil as Second Line Therapy in Autoimmune Hepatitis?"],"prefix":"10.14309","volume":"103","author":[{"given":"Elke M.","family":"Hennes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye H.","family":"Oo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Schramm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Denzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Buggisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Wiegard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Kanzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Schuchmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wulf","family":"Boecher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter R.","family":"Galle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ansgar W.","family":"Lohse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1111\/j.1572-0241.2008.02180.x-BIB1","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMra050408","article-title":"Autoimmune hepatitis","volume":"354","author":"Krawitt Edward","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1572-0241.2008.02180.x-BIB2","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0016-5085(19)33223-8","article-title":"Clinical, biochemical, and histological remission of severe chronic active liver disease: A controlled study of treatments and early prognosis","volume":"63","author":"Soloway","year":"1972","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1572-0241.2008.02180.x-BIB3","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/0016-5085(83)90030-6","article-title":"Autoimmune features as determinants of prognosis in steroid-treated chronic active hepatitis of uncertain etiology","volume":"85","author":"Czaja","year":"1983","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1572-0241.2008.02180.x-BIB4","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/hep.1840080414","article-title":"Maintenance of remission in autoimmune chronic active hepatitis with azathioprine after corticosteroid withdrawal","volume":"8","author":"Stellon","year":"1988","journal-title":"Hepatology"},{"key":"10.1111\/j.1572-0241.2008.02180.x-BIB5","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0016-5085(19)33223-8","article-title":"Clinical, biochemical, and histological remission of severe chronic active liver disease: A controlled study of treatments and early prognosis","volume":"63","author":"Soloway","year":"1972","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1572-0241.2008.02180.x-BIB6","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(73)92125-9","article-title":"Controlled trial of prednisone and azathioprine in active chronic hepatitis","volume":"1","author":"Murray-Lyon","year":"1973","journal-title":"Lancet"},{"key":"10.1111\/j.1572-0241.2008.02180.x-BIB7","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1159\/000199332","article-title":"\u2018Acute\u2019 autoimmune hepatitis","volume":"34","author":"Crapper","year":"1986","journal-title":"Digestion"},{"key":"10.1111\/j.1572-0241.2008.02180.x-BIB8","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0168-8278(99)80065-8","article-title":"Short-term cyclosporine induces a remission of autoimmune hepatitis in children","volume":"30","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"10.1111\/j.1572-0241.2008.02180.x-BIB9","first-page":"771","article-title":"Tacrolimus: A potential new treatment for autoimmune chronic active hepatitis: Results of an open-label preliminary trial","volume":"90","author":"Van Thiel","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1572-0241.2008.02180.x-BIB10","first-page":"571","article-title":"Cyclophosphamide as alternative immunosuppressive therapy for autoimmune hepatitis-report of three cases","volume":"35","author":"Kanzler","year":"1997","journal-title":"Z Gastroenterol"},{"key":"10.1111\/j.1572-0241.2008.02180.x-BIB11","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S0168-8278(98)80128-1","article-title":"Successful treatment of refractory type 1 autoimmune hepatitis with methotrexate","volume":"29","author":"Burak","year":"1998","journal-title":"J Hepatol"},{"key":"10.1111\/j.1572-0241.2008.02180.x-BIB12","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/hep.1840080414","article-title":"Maintenance of remission in autoimmune chronic active hepatitis with azathioprine after corticosteroid withdrawal","volume":"8","author":"Stellon","year":"1988","journal-title":"Hepatology"},{"key":"10.1111\/j.1572-0241.2008.02180.x-BIB13","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/hep.1840180435","article-title":"Meeting report: International Autoimmune Hepatitis Group","volume":"18","author":"Johnson","year":"1993","journal-title":"Hepatology"},{"key":"10.1111\/j.1572-0241.2008.02180.x-BIB14","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1056\/NEJM199510123331502","article-title":"Azathioprine for long-term maintenance of remission in autoimmune hepatitis","volume":"333","author":"Johnson","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1572-0241.2008.02180.x-BIB15","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1023\/A:1010683817344","article-title":"Cyclosporin A is a promising alternative to corticosteroids in autoimmune hepatitis","volume":"46","author":"Malekzadeh","year":"2001","journal-title":"Dig Dis Sci"},{"key":"10.1111\/j.1572-0241.2008.02180.x-BIB16","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0168-8278(99)80065-8","article-title":"Short-term cyclosporine induces a remission of autoimmune hepatitis in children","volume":"30","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"10.1111\/j.1572-0241.2008.02180.x-BIB17","first-page":"771","article-title":"Tacrolimus: A potential new treatment for autoimmune chronic active hepatitis: Results of an open-label preliminary trial","volume":"90","author":"Van Thiel","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1572-0241.2008.02180.x-BIB18","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S0168-8278(98)80128-1","article-title":"Successful treatment of refractory type 1 autoimmune hepatitis with methotrexate","volume":"29","author":"Burak","year":"1998","journal-title":"J Hepatol"},{"key":"10.1111\/j.1572-0241.2008.02180.x-BIB19","first-page":"571","article-title":"Cyclophosphamide as alternative immunosuppressive therapy for autoimmune hepatitis-report of three cases","volume":"35","author":"Kanzler","year":"1997","journal-title":"Z Gastroenterol"},{"key":"10.1111\/j.1572-0241.2008.02180.x-BIB20","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0140-6736(95)92534-1","article-title":"European Mycophenolate Mofetil Cooperative Study Group. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection","volume":"345","year":"1995","unstructured":"20.\u2002European Mycophenolate Mofetil Cooperative Study Group. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. Lancet 1995;345:1321-5.","journal-title":"Lancet"},{"key":"10.1111\/j.1572-0241.2008.02180.x-BIB21","first-page":"768","article-title":"Mycophenolate mofetil versus azathioprine immunosuppressive regimens after lung transplantation: Preliminary experience","volume":"17","author":"Ross","year":"1998","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/j.1572-0241.2008.02180.x-BIB22","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/j.1875-9114.1997.tb03082.x","article-title":"Mycophenolate mofetil","volume":"17","author":"Sievers","year":"1997","journal-title":"Pharmacotherapy"},{"key":"10.1111\/j.1572-0241.2008.02180.x-BIB23","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/00007890-199809150-00007","article-title":"Infectious complications occurring in liver transplant recipients receiving mycophenolate mofetil","volume":"66","author":"Paterson","year":"1998","journal-title":"Transplantation"},{"key":"10.1111\/j.1572-0241.2008.02180.x-BIB24","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0168-8278(00)80271-8","article-title":"Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine","volume":"33","author":"Richardson","year":"2000","journal-title":"J Hepatol"},{"key":"10.1111\/j.1572-0241.2008.02180.x-BIB25","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1155\/2004\/504591","article-title":"Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory to standard therapy","volume":"18","author":"Devlin","year":"2004","journal-title":"Can J Gastroenterol"},{"key":"10.1111\/j.1572-0241.2008.02180.x-BIB26","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1478-3231.2005.01107.x","article-title":"Transplant immunosuppressive agents in non-transplant chronic autoimmune hepatitis: The Canadian association for the study of liver (CASL) experience with mycophenolate mofetil and tacrolimus","volume":"25","author":"Chatur","year":"2005","journal-title":"Liver Int"},{"key":"10.1111\/j.1572-0241.2008.02180.x-BIB27","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.cgh.2007.02.030","article-title":"Mycophenolate mofetil in autoimmune hepatitis patients not responsive or intolerant to standard immunosuppressive therapy","volume":"5","author":"Inductivo-Yu","year":"2007","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["The American Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000434-200812000-00020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:45:27Z","timestamp":1786542327000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000434-200812000-00020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2008,12]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1572-0241.2008.02180.x","relation":{},"ISSN":["0002-9270","1572-0241"],"issn-type":[{"value":"0002-9270","type":"print"},{"value":"1572-0241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}